A2 Biotherapeutics Inc.

5 clinical trials · Sponsor

Record	Firm	Date
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products (NCT06885424)	A2 Biotherapeutics Inc.	2025-07-31
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression (NCT06682793)	A2 Biotherapeutics Inc.	2025-05-22
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression (NCT06051695)	A2 Biotherapeutics Inc.	2024-04-03
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression (NCT05736731)	A2 Biotherapeutics Inc.	2023-04-28
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing (NCT04981119)	A2 Biotherapeutics Inc.	2021-10-29

Every clearance here is in the API, with alerts when new ones post.